Cover Image

Drug-drug interaction between tacrolimus and caspofungin in Chinese kidney transplant patients with different genotypes

Background: The effect of drug-drug interaction between tacrolimus and caspofungin on the pharmacokinetics of tacrolimus in different CYP3A5 genotypes has not been reported in previous studies. Objectives: To investigate the effect of caspofungin on the blood concentration and dose of tacrolimus und...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yundi Zhang (Author), Bowen Shen (Author), Yue Li (Author), Huiying Zong (Author), Xiaoming Zhang (Author), Xiaohong Cao (Author), Fengxi Liu (Author), Yan Li (Author)
Format:	Book
Published:	SAGE Publishing, 2024-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Interaction between tacrolimus and calcium channel blockers based on CYP3A5 genotype in Chinese renal transplant recipients
by: Huiying Zong, et al.
Published: (2024)

CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients
by: Yilei Yang, et al.
Published: (2021)

A fatal case of Trichosporon asahii fungemia and pneumonia in a kidney transplant recipient during caspofungin treatment
by: Yang MF, et al.
Published: (2014)

Tacrolimus Therapeutic Drug Monitoring in Kidney Transplant Patients Before and After Pharmacist Post-transplant Consults
by: Gabriella Massoglia, et al.
Published: (2021)

Drug-drug interactions of tacrolimus
by: Rančić Nemanja K., et al.
Published: (2015)

Genetic Polymorphisms Affecting Tacrolimus Metabolism and the Relationship to Post-Transplant Outcomes in Kidney Transplant Recipients
by: Cheng F, et al.
Published: (2021)

Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation
by: Chang-He Niu, et al.
Published: (2020)

Influence of different formulations of tacrolimus on dosage regimen and drug exposure within the first year after kidney transplantation
by: Stefanović Nikola Z., et al.
Published: (2019)

The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
by: Yi-Chang Zhao, et al.
Published: (2022)

The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Teun van Gelder, et al.
Published: (2020)

Pharmacokinetics of apixaban and tacrolimus or cyclosporine in kidney and lung transplant recipients
by: Holly Mansell, et al.
Published: (2022)

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
by: Seung Seok Han, et al.
Published: (2012)

A case of tacrolimus-induced encephalopathy after kidney transplantation
by: Myoung Uk Kim, et al.
Published: (2011)

Commentary: The Clinical Impact of the C0/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
by: Gerold Thölking, et al.
Published: (2021)

Drug-drug interaction between diltiazem and tacrolimus in relation to CYP3A5 genotype status in Chinese pediatric patients with nephrotic range proteinuria: a retrospective study
by: Qiaoling Yang, et al.
Published: (2024)

Metabolism and transporter based drug-drug interaction of tacrolimus with nine co-medicated injections
by: Qing Xu, et al.
Published: (2021)

Application of Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions between Elexacaftor/Tezacaftor/Ivacaftor and Tacrolimus in Lung Transplant Recipients
by: Eunjin Hong, et al.
Published: (2023)

Limited sampling strategies for estimation of tacrolimus exposure in kidney transplant recipients receiving extended‐release tacrolimus preparation
by: Toqa El‐Nahhas, et al.
Published: (2022)

Therapeutic drug monitoring of tacrolimus in pancreas transplantation at São Lucas Hospital Monitoramento terapêutico de tacrolimus em transplante de pâncreas no Hospital São Lucas
by: Luciana Mello de Oliveira, et al.
Published: (2007)

Application of caspofungin in China compared with amphotericin B and fluconazole
by: Zhang CY, et al.
Published: (2014)

The Utilization Pattern of Caspofungin in an Educational Hospital
by: Soodeh Ramezaninejad, et al.
Published: (2019)

Ciclosporina versus tacrolimus no transplante renal no Brasil: uma comparação de custos Cyclosporine versus tacrolimus in kidney transplants in Brazil: a cost comparison
by: Augusto Afonso Guerra Junior, et al.
Published: (2010)

Tacrolimus Updated Guidelines through popPK Modeling: How to Benefit More from CYP3A Pre-emptive Genotyping Prior to Kidney Transplantation
by: Jean-Baptiste Woillard, et al.
Published: (2017)

Drug interactions of tacrolimus with letermovir and azole antifungals following hematopoietic stem cell transplantation: A retrospective observational analysis
by: Yuri Shinogi, et al.
Published: (2023)

Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation
by: Pere Fontova, et al.
Published: (2021)

USE OF TACROLIMUS IN CHILDREN FOR TRANSPLANTATION OF KIDNEYS TAKEN FROM LIVE RELATIVE DONORS
by: V. A. Goryainov, et al.
Published: (2014)

A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients
by: Kim L. W. Bunthof, et al.
Published: (2022)

Statin therapy for preventing cardiovascular diseases in patients treated with tacrolimus after kidney transplantation
by: Han N, et al.
Published: (2017)

Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus
by: Pasternak AL, et al.
Published: (2021)

Physiologically based pharmacokinetic modeling of tacrolimus for food-drug and CYP3A drug-drug-gene interaction predictions
by: Helena Leonie Hanae Loer, et al.
Published: (2023)

Development and Quality Control of a Population Pharmacokinetic Model Library for Caspofungin
by: Nuo Xu, et al.
Published: (2024)

Meltdose Tacrolimus Population Pharmacokinetics and Limited Sampling Strategy Evaluation in Elderly Kidney Transplant Recipients
by: Jasper Kamp, et al.
Published: (2023)

Relationship between 2-Hour Tacrolimus Concentrations and Clinical Outcomes in Long Term Kidney Transplantation
by: Jeffrey Yin, et al.
Published: (2020)

Monitoring of tacrolimus concentration after kidney or heart transplantation - the importance of intra-subject variability parameters
by: Agnieszka Małgorzata Cios, et al.
Published: (2022)

Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy in Heart Transplantation: New Strategies and Preliminary Results in Endomyocardial Biopsies
by: Simona De Gregori, et al.
Published: (2022)

Case report: Paralytic ileus resulted from nirmatrelvir/ritonavir-tacrolimus drug-drug interaction in a systemic lupus erythematosus patient with COVID-19
by: Wei Zhang, et al.
Published: (2024)

Fighting Emerging Caspofungin-Resistant <i>Candida</i> Species: Mitigating <i>Fks</i>1-Mediated Resistance and Enhancing Caspofungin Efficacy by Chitosan
by: Aya Tarek, et al.
Published: (2024)

Tacrolimus in preventing transplant rejection in Chinese patients – optimizing use
by: Li CJ, et al.
Published: (2015)

Assessment and Development of the Antifungal Agent Caspofungin for Aerosolized Pulmonary Delivery
by: Iching G. Yu, et al.
Published: (2021)

Assessment of omeprazole and famotidine effects on the pharmacokinetics of tacrolimus in patients following kidney transplant-randomized controlled trial
by: Miłosz Miedziaszczyk, et al.
Published: (2024)